GeneMatrix Inc (109820) — Cash Flow-to-Debt Ratio
GeneMatrix Inc (109820) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of ₩500.19 Million could theoretically repay 0% of its total liabilities (₩9.72 Billion) in one year. See cash generation quality of GeneMatrix Inc to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
GeneMatrix Inc Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for GeneMatrix Inc across 11 annual periods. Also explore 109820 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for GeneMatrix Inc (2014–2024)
Year-by-year debt coverage analysis for GeneMatrix Inc. For market capitalisation and broader financial context, see 109820 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.02x | ₩-200.12 Million | ₩9.23 Billion | ▲ +92.4% |
| 2023 | -0.29x | ₩-2.35 Billion | ₩8.21 Billion | ▼ -115.6% |
| 2022 | -0.13x | ₩-1.02 Billion | ₩7.72 Billion | ▼ -128.4% |
| 2021 | 0.47x | ₩3.37 Billion | ₩7.21 Billion | ▼ -50.5% |
| 2020 | 0.94x | ₩4.51 Billion | ₩4.78 Billion | ▲ +647.1% |
| 2019 | -0.17x | ₩-2.28 Billion | ₩13.21 Billion | ▼ -30.3% |
| 2018 | -0.13x | ₩-2.74 Billion | ₩20.68 Billion | ▲ +50.1% |
| 2017 | -0.27x | ₩-1.77 Billion | ₩6.68 Billion | ▼ -387.1% |
| 2016 | -0.05x | ₩-373.25 Million | ₩6.85 Billion | ▲ +1.1% |
| 2015 | -0.06x | ₩-591.96 Million | ₩10.74 Billion | ▲ +79.3% |
| 2014 | -0.27x | ₩-1.38 Billion | ₩5.16 Billion | — |